ArticleMultiple sclerosis journal - experimental, translational and clinical
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab.
Johan Hellgren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.